AVITA Medical, Inc. 8-K

What Happened
AVITA Medical, Inc. announced its financial results for the quarter ended March 31, 2026 by issuing a press release on May 14, 2026. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8‑K under Item 2.02 (Results of Operations and Financial Condition). The filing is signed by David O’Toole, Chief Financial Officer.

Key Details

• Filing date: May 14, 2026 (Form 8‑K).
• Reporting period: Quarter ended March 31, 2026.
• Exhibit: Press release furnished as Exhibit 99.1.
• Signature: Report signed by David O’Toole, CFO of AVITA Medical, Inc.

Why It Matters
This 8‑K indicates AVITA has released its quarterly earnings and other financial information for Q1 2026; investors should read the furnished press release (Exhibit 99.1) to see revenue, earnings, cash position, and any management commentary or guidance. The item is a results disclosure (Item 2.02) rather than a corporate-action notice, so it primarily provides updated quarterly performance data that can affect valuation and trading decisions.